OBJECTIVE: It has been suggested that insulin could regulate the secretion of leptin, the ob gene product, but the ®ndings have been contradictory. Therefore, we studied the association between leptin and insulin secretion and insulin sensitivity in impaired glucose tolerance (IGT). SUBJECTS: 39 obese subjects (17 men, 22 women, body mass index (BMI) 30.6 AE 0.6 kg/m 2 , age 54 AE 1 y, mean -AE s.e.m.) with IGT. MEASUREMENTS: Leptin, insulin sensitivity and ®rst-phase insulin response (frequently sampled intravenous glucose tolerance test), anthropometry, infrared densitometric assay. RESULTS: Leptin correlated with BMI (r 0.36, P 0.022), fat percent (r 0.74, P`0.001) and fat mass (r 0.53, P`0.001). After adjustment for sex and fat mass, leptin showed no signi®cant linear correlation with fasting insulin, insulin sensitivity or ®rst-phase insulin response. CONCLUSION: In obese IGT subjects fat mass is the main correlate of serum leptin concentration. First-phase insulin response or the degree of insulin resistance are not associated with leptin in IGT.
Introduction
The ob gene protein, leptin, regulated body weight in mice. 1 However, the knowledge of the physiological role of leptin in humans is still limited. Leptin levels are increased in obese subjects and leptin correlates strongly with body mass index (BMI) and the amount of body fat. 2 Recently, the role of insulin in the regulation of leptin secretion has been investigated. Long-term hyperinsulinaemia lead to an increase of ob mRNA in rat adipose tissue, 3 and a prolonged exposure to high insulin concentrations during a 8.5 h hyperinsulinaemic clamp increased leptin concentrations in humans. 4 Impaired glucose tolerance (IGT) is commonly associated with both obesity and disturbances in insulin secretion and/or insulin resistance, but only limited data are available as to the role of leptin in this condition. In the present study, we examined the association between insulin metabolism and serum leptin in a well-characterized group of obese subjects with impaired glucose tolerance (IGT). In particular, we studied whether ®rst-phase insulin secretion in this condition could be a determinant of serum leptin levels.
Methods

Subjects
Thirty nine subjects (17 men, 22 women) with IGT according to the WHO criteria 5 were investigated. The diagnosis of IGT was based on two consecutive oral glucose tolerance tests (OGTT) (the mean of the two 2 h plasma glucose values between 7.8±11.0 mmol/l). Fasting glucose during OGTT averaged 6.2 AE 0.1 mmol/l and 2 h glucose 9.0 AE 0.1 mmol/l, respectively. Other inclusion criteria were: age 40±65 y and BMI at least 25 kg/m 2 . All subjects gave their informed consent and the study was approved by the Ethics Committee of the University of Kuopio and Kuopio University Hospital.
Study protocol
On the ®rst visit, which was performed in the morning after an overnight fast, a blood sample for the determination of serum leptin concentration was drawn and anthropometric measurements were performed. Frequently sampled intravenous glucose tolerance test (IVGTT) was performed on the second visit within a three-week interval. Fasting glucose and insulin were measured twice in the beginning of the IVGTT and their mean value was used. The patients' weight did not change between the visits. . Waist and hip circumferences were measured by standard methods and waist±hip ratio (WHR) was calculated. Body composition was assessed by infrared densitometric assay (Futrex 5000, Futrex Inc., USA) from the nondominant arm in the line between the olecranon and the acromion. 6 Leptin was measured by a commercial radioimmunoassay (Linco Research Inc., St. Louis, MO, USA). 7 IVGTT was performed as previously described. 8 First, after an overnight fast the two baseline blood samples for the measurements of plasma glucose and insulin were drawn. The mean values of the two glucose and two insulin concentrations were used in further analysing the relationships between leptin, glucose and insulin. A glucose dose of 0.3 g/kg was injected intravenously within 1.5 min and frequent blood sampling was started. At 20 min, an insulin bolus (0.03 IU/ kg) was given. On the basis of plasma glucose and insulin concentrations during the 3 h test, the insulin sensitivity index (S I ) was calculated. 9 First-phase insulin response was calculated as the insulin area under the curve during 0±10 min. Measurements of insulin sensitivity and ®rst-phase insulin response are available in 32 out of 39 subjects. Plasma glucose was measured by the glucose oxidase method (Glucose Auto & Stat, model GA-110, Kyoto, Japan) and insulin by the RIA-method (Phadeseph Insulin RIA 100, Pharmacia Diagnostics, Uppsala, Sweden).
Statistical analysis
Results are given as mean AE s.e.m. The normal distribution of the variables was checked with the Kolmogorov±Smirnov test. If the variable was not normally distributed, it was log-transformed. Relationships between the variables were analysed by using Pearson and partial correlation coef®cients. Differences between the groups were analysed by Student's t-test and by analysis of variance and covariance.
Results
The characteristics of the subjects are shown in Table  1 . Men had a higher lean body mass than women and in turn, women had a higher percentage body fat. Serum leptin level was signi®cantly higher in women than in men even after controlling for fat mass. Leptin correlated with BMI (r 0.36, P 0.022), percentage body fat (r 0.74, P`0.001) and fat mass (r 0.53, P`0.001). Leptin was positively correlated with WHR in men (r 0.56, P 0.021), but not in women (r 70.01, P 0.99).
Fasting insulin and glucose, insulin sensitivity and ®rst-phase insulin response did not differ between men and women ( Table 1) . Leptin had no signi®cant linear correlation with fasting insulin (r 0.26, P 0.12), insulin sensitivity (r 70.11, P 0.54) or ®rst-phase insulin response (r 70.11, P 0.56). After adjustment for sex and fat mass, the correlation coef®cient between leptin and fasting insulin was 0.23 (P 0.22), between leptin and insulin sensitivity 70.06 (P 0.75), and between leptin and ®rst-phase insulin response 70.15 (P 0.42). In addition, glucose levels were not related to serum leptin (data not shown).
When subjects were divided into tertiles by fasting insulin, insulin was signi®cantly associated with leptin level (P 0.046), but the association weakened to a non-signi®cant level after adjustment for sex and fat mass (Figure 1a±c ). Tertiles of insulin sensitivity and ®rst-phase insulin response had no signi®cant association with leptin. However, after adjustment for sex and fat mass the association between insulin sensitivity and leptin level became stronger, but did not reach statistical signi®cance (P 0.14) (Figure 1 ).
Discussion
Impaired glucose tolerance, a common obesity-related disorder, is characterized by hyperinsulinaemia and insulin resistance. Insulin secretory response to glucose may also be disturbed. Although the regulatory role of insulin on leptin has been suggested, only very limited data concerning the interaction between leptin and insulin in this condition are available. Our main ®nding was that in obese subjects with IGT, insulin sensitivity or insulin secretion capacity as measured by ®rst-phase insulin secretion were not signi®cantly associated with serum leptin level. A recent study of Larsson et al 10 showed that insulin secretion was associated with serum leptin in women with normal glucose tolerance (NGT), but not in women with IGT. In that study, insulin sensitivity showed a borderline correlation with leptin (P 0.052) in IGT, but not in NGT. 10 In another study lean insulin-sensitive men had a lower leptin concentration than the insulinresistant men with similar amount of fat; 11 however, only normoglycamic subjects were included in that study. Our results are in agreement with those of Larsson et al, 10 showing that in subjects with IGT the interaction between leptin and insulin is not signi®-cant. However, it must be emphasized that we studied a well-characterized group of insulin-resistant IGT subjects, and our conclusion concerning the lack of the interaction between leptin, insulin sensitivity and beta-cell function is applicable only for this group.
It is generally accepted that BMI and the amount of body fat are associated with leptin, and also that women have higher leptin levels than men, 2 probably due to the higher percentage body fat. On the basis of recent studies, it has been suggested that insulin may have a role in regulating leptin secretion. Animal studies have shown that an insulin injection 12 and long-term hyperinsulinaemia 3 lead to an increase of ob mRNA in the adipose tissue, whereas fasting was associated with decreases in both serum insulin and leptin. 3 A recent study demonstrated that prolonged exposure to high insulin concentrations during a 8.5 h hyperinsulinaemic clamp increased leptin concentrations in humans; 4 similarly, long-term hyperinsulinaemia lead to increased expression of ob gene and a rise in leptin concentration. 13 However, neither acute hyperinsulinaemia 13 nor marked alterations in plasma insulin concentration during IVGTT 11 had an effect on leptin concentrations. Thus, it seems that under experimental conditions, insulin may be involved in the chronic, but not acute regulation of leptin; 14 however, its physiological signi®cance is still to be determined. The stimulatory effect of insulin on leptin secretion may be the consequence of the trophic effect of insulin on adipocytes.
14 Since insulin secretory capacity as measured with ®rst phase insulin response was not associated with serum leptin, it seems that insulin is not an essential factor in regulating leptin in IGT. It is possible that in IGT subjects with disturbed insulin secretion and action, the regulation of leptin by insulin is altered. The present study con®rms the previous results based on NIDDM patients, 15 and extends them to IGT, showing that the adiposity is the main determinant of serum leptin in various degrees of glucose intolerance.
Conclusions
In insulin-resistant IGT subjects serum leptin was strongly correlated with the amount of body fat. The À4 min À1 /mU/ml, II 1.24±2.24 10 À4 min À1 /mU/ml and III 2.25±4. 1 10 À4 min À1 /mU/ml). P 0.65 and P 0.14 after adjustment for sex and fat mass (ANOVA).
Figure 1c
Serum leptin in relation to tertiles of ®rst-phase insulin response (FPIR) (I 22±139 mU/l Á min, II 140±258 mU/ l Á min and III 259±928 mU/l Á min). P 0.85 and P 0.56 after adjustment for sex and fat mass (ANOVA). degree of insulin resistance or ®rst-phase insulin secretion were not related to serum leptin concentration.
